The global market for vaccine technologies reached $33.3 billion in 2016 and should reach $45.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2021.
-An overview of the global market for human and animal (veterinary) vaccines
-Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
-A review of vaccine technology and its challenges, innovations, opportunities and regulatory hurdles
-Evaluations of market sizes and developments for vaccine classes (prophylactic and therapeutic), vaccine types (inactivated, conjugate, attenuated, recombinant vector, subunit, toxoid, combination and dendritic cells), vaccine end-users (humans and animals) and disease indications (infectious, cancer and allergy)
-Examination of industry environment, strategies, market influences and driving forces
-Identification of regional market sizes, prices and trends
-Analysis of relevant patents
-Profiles of major players in the industry
Vaccines are an important part of the global healthcare market. Human vaccines areavailable for a wide range of diseases such as polio; measles, mumps and rubella (MMR); tetanus; diphtheria; hepatitis and influenza. Animal health vaccines offer applications such as antibiotics, parasiticides and medicinal feed additives and vaccines for both livestock and companion animals. It’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for vaccine technology.The outlook of the market, the setbacks and the needs of the market are discussed in this report. The classifications and usage of these products are also described in this report.A detailed analysis of the vaccine technology industry’s structure has been conducted. The revenues are broken down by region, while sales figures are estimated for the five-year period from 2016 through 2021. The applications of these vaccines are discussed separately in the report. The report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDY
Vaccines are one of the most cost-effective ways to reduce the global disease load. The global rise in infectious and noninfectious diseases, the growing population, advancements in science and technology, as well as the resurgence of vaccine preventable diseases and the emergence of new pandemics and immunization programs run in developing geographies are influencing the global vaccines market. In humans, vaccines are used to prevent or treat various human diseases. Based on whether they prevent diseases or treat pre-existing ones, vaccines can be divided broadly into prophylactic and therapeutic vaccines. In contrast, animal vaccines are categorized for food-producing animals (porcine, bovine, poultry, ovine, fish) and for companion animals (canine, feline and equine vaccines) and other animal vaccines (rabbit, etc.).Research and development (R&D spending, along with increasing competition and new technologies are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth. This study looks at almost all the systems affected by these factors.Acquisition strategies and collaborations by companies are also covered in this report. In addition, this study also discusses the strengths and weaknesses of each strategy type in light of the new technologies, growing competition and changing customer needs.The market also has been analyzed based on the application of these vaccines. Categories considered in this report are meningococcal/pneumococcal vaccines, influenza vaccines, pediatric polio/pertussis/Hib vaccines, adult/adolescent booster vaccines, vaccines for travel-related and other endemic diseases, HPV vaccines, rotavirus vaccines and other (minor) vaccines.
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
This study contributes to the areas of market growth among vaccine manufacturers and users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings as well as pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study entails the current market for human and animal vaccines. The report also includes regulatory aspects, current and developing technologies, market projections and market share. An analysis of patents, clinical trials, innovations and opportunities, as well as the latest trends is also discussed.Sales data for the global and regional markets were corroborated for the present and forecasted values based on statistical analysis. Regions are categorized into the United States, Europe and the emerging markets, which include India, China, Japan, South Korea, Taiwan, Canada, Africa, Australia and New Zealand. The application of vaccines in various diseases is discussed from both a commercial and R&D perspective.
Both primary and secondary research methodologies were used in preparing this study. It conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers and users of vaccine technology products. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of vaccine technology. Data were gathered from various industry sources. In addition, interviewed industry officials, consulted newsletters, company literature, product literature and various technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.
Table of Contents
2. Executive Summary
4. Regulatory Aspects
5. New Developments
6. Market Analysis Of Human Vaccines
7. Market Analysis Of Animal Vaccines
8. Industry Structure
9. Market By Application For Human Vaccines
10. Patent Analysis
11. Current Situation
12. Company Profiles
For More Related Reports: Vaccine Market Research Reports
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Our Blog: https://www.bharatbook.com/blog/
Follow us on Facebook: https://www.facebook.com/BharatBook3B
Follow us on Twitter: https://twitter.com/researchbook
Follow us on Linked In: http://www.linkedin.com/company/bharat-book-bureau
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.